Resultados de la búsqueda 1851-1860 of 15503 for Crohns disease
... disease post-neoadjuvant chemotherapy, and to evaluate the safety of multi-epitope HER2 vaccine given concurrently with T-DM1 maintenance therapy. A ...
... disease and recurrence. A Study to Evaluate ... and trispecific antibodies and the factors that may determine disease progression and treatment response.
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Centers for Disease Control and Prevention. https ... Physical Fitness Assessments and Norms for Adults and ... Cómo mantenerte activo con la enfermedad de Crohn ...
... and have had follow-up radiation therapy (but not surgery) and are in complete remission (no evidence of disease). This is an investigational study ...
The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first 4 ...
Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either ...
... disease-condition/hemorrhoids-expanded-version. Accessed Feb. 22, 2023. Kwaan MR. Hemorrhoids, anal fissure, and anorectal abscess and fistula. In: Conn's ...
Connect with others like you for support and answers to your questions in the Breast Cancer support group on Mayo Clinic Connect, a patient community.
The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?